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Abstract
Background & objectives: There is paucity of information on the association between Plasmodium
falciparum malaria and some human genetic markers in the Niger Delta region of Nigeria. Hence,
a study was undertaken in children to assess the current level of subclinical malaria due to P.
falciparum.
Methods: Blood groups ABO and Rhesus factor, haemoglobin electrophoretic pattern, G-6-PD
deficiency status and malaria were determined among 240 apparently healthy children in a cross-
sectional descriptive study using standard procedures.
Results: The prevalence of P. falciparum malaria in this region was high (27.5%). Blood group O
(51.3%) dominated the study population, followed by B (23.8%), A (21.3%), and AB (3.8%).
Rhesus D positive accounted for 91.3% while Rh D negative was 8.7%. Sickle-cell trait (HbAS)
prevalence was 12.5%  while HbAA accounted for 87.5%. In all, 5.42% of the children were G-6-
PD deficient while 94.58% had normal G-6-PD status. Chi-square analysis revealed that only
blood group O and Rh D negative had a significant association with P. falciparum malaria (2=
4.3636, p <0.05 and 2 = 5.760, p <0.02 respectively). No significant association was found to
exist between P. falciparum malaria and other genetic markers.
Conclusion: This study has provided the current prevalence rates of some genetic markers in a
malaria endemic region of Niger Delta, Nigeria. Of all the genetic markers tested, only Blood
group O and Rh D negative had significant and positive associations with P. falciparum infection.
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Introduction
Despite all efforts to roll back malaria in Africa, the
malaria parasite Plasmodium falciparum still remains
the leading cause of child mortality which annually
kills >1 million children in Africa alone. This death
toll is only one aspect of the global burden of ma-
laria1. In Nigeria, malaria still constitutes a serious
health problem. It is responsible for 60% outpatient
visits to health facilities, 30% childhood deaths, 25%
of deaths in children under one year and 11% of ma-
ternal deaths (4500 die yearly)2. In Nigeria, a child
will be sick of malaria between 2 and 4 times in one
year and 70% of pregnant women suffer from ma-
laria contributing to maternal anaemia, low birth
weight, still birth, abortion and other pregnancy re-
lated complications. The financial loss due to ma-
laria annually is estimated to be about 132 billion
naira in the form of treatment cost, prevention, loss
of man-hours etc2. In regions of high malaria trans-
mission, every member of the community might be
chronically infected and as such there could be a high J  VECTOR  BORNE  DIS  47, MARCH 2010 12
prevalence of sub-clinical malaria3. Plasmodium
falciparum has been called “the strongest known
force for evolutionary selection in the recent history
of human genome”4. Thus, it has been hypothesized
that P. falciparum has shaped the distribution of ABO
blood groups in man, i.e. the current worldwide dis-
tribution of ABO groups is consistent with an effect
from P. falciparium and that certain blood groups
protect humans from the lethal effect of P. falciparum
infection5. Malaria has also been hypothesized as the
evolutionary driving force behind sickle-cell disease,
glucose-6-phosphate dehydrogenase (G-6-PD) de-
ficiency  and other erythrocyte defects like Duffy null
phenotype4. It has been reported that HbS homozy-
gotes suffer from sickle-cell disease but heterozy-
gotes (HbAS) have a 10-fold reduced risk of severe
P. falciparum malaria6,7.
Deficient G-6-PD enzyme activity has also been
shown to correlate with protection against severe
malaria in Nigerian children8. A study of more than
2000 Gambian and Kenyan children found that
the common African form of G-6-PD deficiency
(G-6-PDA–) is associated with about 50% reduced
risk of severe malaria in female heterozygotes and in
male hemizygotes. Reduced parasite replication in
G-6-PD deficient erythrocytes is thought to be the
mechanism of protection9 but the parasite appears
to counter this by manufacturing G-6-PD itself10.
The main objective of this study was to assess the
current level of subclinical malaria due to P.
falciparum in the Niger Delta region of Nigeria, the
prevalence of some genetic markers among children
and evaluate the extent of association between P.
falciparum and these genetic markers.
Material & Methods
Study area: This study was conducted between March
2005 and April 2006 in Rumueme, Port Harcourt
Nigeria. The geographical location is latitude 447’
21” and longitude 659’ 55”. The study area lies in a
typical deltaic wetlands (Niger Delta) and perennial
malaria transmission is present. The study population
consisted of 240 children aged 1–8 yr of both sexes
recruited from households and schools in a cross-
sectional descriptive study. All the children had
auxiliary body temperature of <37.5°C. None had
symptoms suggestive of malaria or any other systemic
illness. After obtaining informed consents from their
parents, the children were brought to the research
center where 2 ml of blood sample was collected into
ethylenediamine tetracetic acid (EDTA) containing
tubes. This study received ethical approval from the
Rivers State University of Science and Technology,
Port Harcourt, Nigeria. Plasmodium falciparum
diagnosis was done using microscopic examination
of Giemsa stained thin and thick blood smears under
oil immersion lens at x100 magnification. PCR
techniques could not be employed for the diagnosis
due to some technical constraints and higher cost.
Haemoglobin electrophoretic pattern of the partici-
pants were determined using haemoglobin electro-
phoresis by cellulose acetate membrane at pH 8.9 as
described by Brown11. Haemolysates from blood
sample of known haemoglobin (i.e. AA, AS, AC)
were included as controls. A qualitative determina-
tion of G-6-PD in red cells of participants was car-
ried out using the G-6-PD deficiency screen reagent
set (Pointe Scientific, USA. Lot 513704). Red cell
phenotyping was carried out with standard tube tech-
niques as described by Brecher12. ABO blood group-
ing was done using anti-A, anti-B and anti-AB
(Biotec, Ipswich, UK) agglutination method. Rhesus
D typing was done using anti-D serum (Biotec,
Ipcswich, UK) agglutination method and the nega-
tive results were confirmed using the indirect agglu-
tination test (IAT) procedure.
Statistical analysis: Data were analyzed using SPSS
(version 12) for windows (SPSS Inc, Chicago). Sta-
tistical analysis included frequency distribution and
chi-square test for measure of association and p <0.05
were considered statistically significant.
Results
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population is presented in Table 1. As the P.
falciparum prevalence was 27.5%, our null hypoth-
esis therefore, was that for any given genetic marker,
the percentage of individuals with P. falciparum
parasitaemia should be 27.5% and the percentage
with no parasite should be 72.5% and if a given ge-
netic marker has an association with asymptomatic
parasitaemia, it would cause a significant deviation
from the null hypothesis. Based on this, Chi-square
values were calculated for any given genetic marker
for the parasitized (asymptomatic) and non-parasit-
ized group. Table 2 shows the frequencies of human
genetic markers and association with P. falciparum
malaria. The distribution of ABO and Rh blood
groups are as follows: O (51.3%), B (23.8%), A
(21.3%), AB (3.8%), Rh D positive (91.3%) and Rh
D negative (8.7%). A significant association was
found to exist only between blood group O, Rh D
negative and P. falciparum malaria. This association
is a positive association that 33 in group O subjects
were expected to be parasitized, but more (45) were
observed to be parasitized, and out of five in Rhesus
D negative group expected, nine were parasitized
(Table 2).
Similarly, no association was found to exist between
haemoglobin electrophoretic phenotypes and P.
falciparum malaria, 12.5% were HbAS while 87.5%
were HbAA. Of the 12.5%, HbAS, 6 (2.5%) were
infected with malaria. G-6-PD deficient subjects ac-
counted for 5.42% out of which 4 (1.6%) were para-
sitized. No association was also found to exist be-
tween G-6-PD status and P. falciparum parasitaemia
(Table 2).
Discussion
In the last 20 years, there has been increasing evi-
dence that blood groups have a function and play a
biological role in disease association especially ma-
laria. Much of these reports relate to severe malaria
with little or no reference to subclinical or asymp-
tomatic infection. Children were chosen as subjects
because they belong to the most vulnerable group to
P. falciparum infection. In this study, group O sub-
jects dominated the study population, followed by
B, A, and AB which is in consistent with previous
reports that group O is the dominant blood group
among Nigerians13,14.
Group O individual lack the terminal glycosyl trans-
ferases necessary to produce A or B antigen and carry
the disaccharide H antigen (Fuc1–2 Gal1). The
A and B trisaccharides are thought to act as recep-
tors for rosetting on uninfected erythrocytes and di-
rect binding between the parasite rosetting ligand
PfEMP1 and the A antigen has been demonstrated.
P. falciparum rosettes are able to form in group O
Table 1. Prevalence of asymptomatic malaria among
240 children in Port Harcourt, Nigeria
Age groups P. falciparum Total (%) 2
(yr) positive (%)
1– 5 36 (36.36) 99 (41.25) 2.832ns
5 – 9 30 (21.3) 141 (58.75) 1.985ns
Total 66 (27.5) 240 (100)
ns–Non-significant.
Table 2. Frequencies of human genetic markers and
P. falciparum malaria in Niger Delta, Nigeria
Parameter Parasitized Non- Total 2
parasitized
Blood groups
A 9 (3.8) 42 (17.5) 51 (21.3) 1.785ns
B 9 (3.8) 48 (20) 57 (23.8) 1.066ns
O 45 (18.8) 78 (32.5) 123 (51.3) 4.364*
AB 3 (1.3) 6 (2.5) 9 (3.8) 0.150ns
Rh factor
D positive 57 (23.8) 162 (67.5) 219 (91.3) 0.150ns
D negative 9 (3.8) 12 (5.0) 21 (8.7) 5.760*
Hb Electrophoretic pattern
AA 60 (25) 150 (62.5) 210 (87.5) 0.083ns
AS 6 (2.5) 24 (10.0) 30 (12.5) 0.843ns
G-6-PD
Normal 62 (26.3) 165 (68.8) 227 (94.58) 3.735ns
Deficient 4 (1.6) 9 (3.75) 13 (5.42) 0.148ns
*Significant association with malaria (p <0.05); ns – Non-significant;
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cells but these rosettes tend to be smaller and more
easily disrupted than rosettes formed in group A, B
or AB erythrocytes. Thus, through this mechanism
of rosetting and cytoadherence, blood group O is
able to protect against severe P. falciparum malaria15.
There is a high prevalence of subclinical malaria
(27.5%) in this region even among children. A sig-
nificant association was seen to exist between blood
group O and P. falciparum malaria which is in con-
sonance with few cross-sectional studies involving
asymptomatic children16,17 and few longitudinal and
case-control studies involving apparently healthy
children18,19. However, this study is at variance with
almost all the studies in Nigeria where absence of
significant association was observed between ‘P.
falciparum and ABO blood group20–23. Evidence
from the literature has established that parasitized
erythrocytes form rosettes more readily with RBCs
of either A, B or AB blood groups than with those
belonging to blood group O24,25. It is also well es-
tablished that this parasite-triggered RBC rosette
formation is associated with the severity of clinical
disease24. This may explain why severe malaria, lower
haemoglobin levels, jaundice or central nervous sys-
tem disorders were relatively more frequent in indi-
viduals of non-O blood groups as was observed in
Zimbabwe17. However, this study observed that more
than expected, number of subjects were significantly
infected with P. falciparum malaria. The implication
is that the association between blood group O and
malaria is a positive association.
Concerning the Rh system, an association with
Rhesus D negative was established with malaria in
this study. Earlier report showed that E phenotype
individuals exhibited a higher number of malaria epi-
sodes than ee phenotype26. No literature was encoun-
tered that supported the association of Rhesus D
negative blood group with P. falciparum infection.
Since long, it has been known that sickle-cell trait
(HbAS) affords protection against P. falciparum in-
fection27. In our data, no significant association be-
tween AS phenotype and malaria was established.
The difference between the expected and observed
counts was not significant. However, a number of
mechanisms have been proposed to mediate the pro-
tection afforded by HbAS; these include accelerated
sickling of parasite infected HbAS erythrocytes, poor
parasite invasion and growth rates in HbAS erythro-
cytes, and enhanced phagocytosis of infected eryth-
rocytes but the relative contribution of any or all of
these in vivo is not known28. Recent reports indicate
that the sickle-cell trait is associated with enhanced
immunoglobulin G antibody responses to P.
falciparum variant surface antigens29. This may prob-
ably apply in severe infection rather than asymptom-
atic state.
An important form of defense against oxidative stress
within the erythrocyte is the production of the elec-
tron donor nicotinamide dinucleotide phosphate by
the enzyme G-6-PD. This enzyme is encoded by
G-6-PD on chromosome X of which many different
variants are known, and those that markedly com-
promise enzyme activity result in hemolytic anaemia4.
In Africa, the dominant strain that is associated with
protection against severe P. falciparum is G-6-PD
A–8. In a recent report, the X-linked G-6-PD defi-
ciency has been found to protect homozygous males
but not heterozygous females against malaria30. In
this study, we did not genotype to isolate the strain
prevalent here in Port Harcourt. This study only
screened the children for G-6-PD deficiency of which
5.42% were deficient. The sex differences were not
studied either, however, we found no association be-
tween G-6-PD status and P. falciparum infection in
this study.  It is noteworthy that in our setting, PCR
techniques have not been introduced as a routine
procedure for malaria detection probably due to
costs, hence microscopic examination still remains
the method of choice in a developing country such
as ours. The implication is that the prevalence rate
may be lower in cases of subclinical malaria. Sensi-
tive procedures like the PCR if used could pick some
of the parasites that would have been missed by mi-
croscopy.
This study has provided the current prevalence rates
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of Niger Delta, Nigeria. Of all the genetic markers
tested, only blood group O and Rhesus D negative
had significant associations with P. falciparum in-
fection but sadly enough, this association was not
found to be favourable and needs to be confirmed.
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